February 8-9, 2018 at Yale Law School
The Solomon Center for Health Law and Policy at Yale Law School, in collaboration with Smilow Cancer Hospital and Yale Cancer Center, will host a major interdisciplinary conference addressing topics at the cutting edge of cancer policy. This event will bring together leading figures in the worlds of cancer care, research, regulation, and policymaking to assess the current state of cancer policy and discuss ways in which law can influence its development.
Speakers will examine the role Washington, D.C. plays in cancer research and treatment—through politics, legislation, and lobbying as well as by incentivizing and protecting research—and the ways cancer is shaped outside the federal government, including through private entities such as cancer centers and insurance companies, and through state governments. The conference will address special challenges in drug development and pricing as well as how cutting-edge advances in cancer treatment—including precision medicine, immunotherapy, and improvements in the genetic profiling of tumors—interface with existing and proposed government regulations. Speakers will also consider how disparities and inequalities impact cancer research, regulation, and treatment.
The conference is free; however, registration is required.
Siddhartha Mukherjee, MD, DPhil
Pulitzer Prize-Winning Author of The Emperor of All Maladies and Assistant Professor of Medicine, Columbia University Medical Center
Norman Sharpless, MD
Director, National Cancer Institute
Harold Varmus, MD
Lewis Thomas University Professor of Medicine, Weill Cornell Medical College; Nobel Prize Laureate; Former Director of the National Cancer Institute and the National Institutes of Health; and former President and CEO of Memorial Sloan Kettering Cancer Center
Conference Speakers
(more in progress)
Peter Bach, MD, MAPP: Director of the Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
Edward Benz, MD: President and CEO Emeritus, Dana-Farber Cancer Institute
Gideon Blumenthal, MD: Deputy Director (acting), Office of Hematology Oncology Products, U.S. Food and Drug Administration
Otis Brawley, MD: Chief Medical Officer, American Cancer Society
Howard Forman, MD, MBA: Professor of Radiology and Biomedical Imaging, Public Health (Health Policy), Management, and Economics at Yale University
Charles Fuchs, MD, MPH: Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital
Levi Garraway, MD, PhD: Senior Vice President, Global Development & Medical Affairs, Eli Lilly; Director, Joint Center for Cancer Precision Medicine
Abbe Gluck, JD: Professor of Law and Faculty Director, Solomon Center for Health Law and Policy, Yale Law School
Nancy Goodman, JD, MPP: Executive Director, Kids Against Cancer
Cary Gross, MD: Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases), Yale School of Medicine
Peggy Hamburg, MD: Foreign Secretary, National Academy of Medicine; former Commissioner of the FDA (2009-2015)
Roy Herbst, MD, PhD: Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology, Yale School of Medicine; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital
Amy Kapczynski, JD: Professor of Law and Faculty Director, Global Health Justice Partnership, Yale Law School
Aaron Kesselheim, MD, JD, MPH: Associate Professor of Medicine, Harvard Medical School; Director of the Program on Regulation, Therapeutics and Law at Brigham and Women’s Hospital
Jorge Lopez, Jr., JD: Executive Vice President and General Counsel, Memorial Sloan Kettering Cancer Center
Abe Lopman, MBA: Senior Vice President, Operations; Executive Director, Smilow Cancer Hospital at Yale New Haven
Dayna Bowen Matthew, JD: William L. Matheson and Robert M. Morgenthau Distinguished Professor of Law, University of Virginia School of Law
Barbara McAneny, MD: Co-Founder and CEO, New Mexico Oncology Hematology Consultants; President-Elect, American Medical Association
Lee Newcomer, MD, MHA: Senior Vice President, Oncology, Genetics and Women’s Health, UnitedHealthcare
Randall Oyer, MD: Medical Director, Oncology Program, Lancaster General Hospital
Blase Polite, MD: Associate Professor of Medicine, University of Chicago Medical Center
Katerina Politi, PhD: Associate Professor, Yale School of Medicine
Nicholson Price, JD, PhD: Assistant Professor of Law, University of Michigan Law School
David Pugach, JD: Senior Vice President, Public Policy, American Osteopathic Association; Former Vice President of Federal Relations, American Cancer Society Cancer Action Network
Gregory Raskin, MD: Vice President, Technology Development, Memorial Sloan Kettering Cancer Center
Jessica Roberts, JD: Associate Professor, George Butler Research Professor of Law, and Director of the Health Law and Policy Institute, University of Houston Law Center
Joseph Ross, MD, MHS: Associate Professor of Medicine (General Medicine) and Associate Professor of Public Health (Health Policy), Yale School of Medicine
Eugene Rusyn, JD: Lecturer in Law and Senior Fellow, Solomon Center for Health Law and Policy, Yale Law School
Charles Sawyers, MD: Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
Richard Schilsky, MD: Chief Medical Officer, American Society of Clinical Oncology
Deborah Schrag, MD, MPH: Chief, Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School
Ellen Sigal, PhD: Chairperson and Founder, Friends of Cancer Research
Lindsay Wiley, JD, MPH: Professor of Law and Director, Health Law and Policy Program, American University Washington College of Law
Agenda
All events listed below will take place at Yale Law School (127 Wall St., New Haven, CT)
Thursday, February 8, 2018
3:00 p.m. – 4:00 p.m.
Registration and Refreshments
Venue: Room 122
4:00 p.m.
Welcome & Opening Remarks
Venue: Levinson Auditorium
4:10 p.m. – 5:30 p.m.
Panel 1: Is the Federal Government a Productive Partner in Cancer Policy?
Venue: Levinson Auditorium
Moderator:
Abbe Gluck, JD—Professor of Law and Faculty Director, Solomon Center for Health Law and Policy, Yale Law School
Panelists:
- Nancy Goodman, JD, MPP—Executive Director, Kids Against Cancer
- Peggy Hamburg, MD—Former Commissioner of the FDA (2009-2015)
- David Pugach, JD—Former Vice President of Federal Relations, American Cancer Society Cancer Action Network
- Richard Schilsky, MD—Chief Medical Officer, American Society of Clinical Oncology
- Harold Varmus, MD—Lewis Thomas University Professor of Medicine, Weill Cornell Medical College. Former Director of the National Cancer Institute and the National Institutes of Health, and former President and CEO of Memorial Sloan Kettering Cancer Center
5:30 p.m. – 6:45 p.m.
Keynote Address
Venue: Levinson Auditorium
Siddhartha Mukherjee, MD, DPhil—Pulitzer Prize-Winning Author of The Emperor of All Maladies and Assistant Professor of Medicine, Columbia University Medical Center
Introduced by:
Charles Fuchs, MD, MPH—Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital
6:45 p.m. – 7:30 p.m.
Reception
Venue: Ruttenberg Dining Hall
Friday, February 9, 2018
8:00 a.m. – 8:45 a.m.
Registration and Breakfast
Venue: Room 122
Friday’s panels will take place in either the Levinson Auditorium or Room 127 at Yale Law School. Check with the registration desk for details.
8:45 a.m. – 10:15 a.m.
Panel 2: The Business of Cancer
Moderator:
Howard Forman, MD, MBA—Professor of Radiology and Biomedical Imaging, Public Health (Health Policy), Management, and Economics at Yale University
Panelists:
- Ed Benz, MD—President and CEO Emeritus, Dana-Farber Cancer Institute
- Abe Lopman, MBA—Senior Vice President, Operations; Executive Director, Smilow Cancer Hospital at Yale New Haven
- Barbara McAneny, MD—Co-Founder and CEO, New Mexico Oncology Hematology Consultants; President-Elect, American Medical Association
- Lee Newcomer, MD, MHA—Senior Vice President, Oncology, Genetics and Women’s Health, UnitedHealthcare
- Randall Oyer, MD—Medical Director, Oncology Program, Lancaster General Hospital
- Gregory Raskin, MD—Vice President, Technology Development, Memorial Sloan Kettering Cancer Center
10:15 a.m. – 10:30 a.m.
Coffee Break
10:30 a.m. – 12:00 p.m.
Panel 3: Cancer, Health Justice, and Disparities
Moderators:
Cary Gross, MD—Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases), Yale School of Medicine
Eugene Rusyn, JD—Yale Law School
Panelists:
- Dayna Bowen Matthew, JD—William J. Matheson and Robert M. Morgenthau Distinguished Professor of Law, University of Virginia School of Law
- Otis Brawley, MD—Chief Medical Officer, American Cancer Society
- Blase Polite, MD—Associate Professor of Medicine, University of Chicago Medical Center
- Lindsay Wiley, JD, MPH—Professor of Law and Director, Health Law and Policy, Program, American University Washington College of Law
12:00 p.m. – 1:15 p.m.
Lunch Keynote
Venue: Ruttenberg Dining Hall
Norman Sharpless, MD—Director, National Cancer Institute
1:30 p.m. – 3:00 p.m.
Panel 4: Drug Development and the Cost of Researching and Treating Cancer
Moderator/Panelist:
Charles Fuchs, MD, MPH—Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital
Panelists:
- Peter Bach, MD, MAPP—Director of the Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
- Gideon Blumenthal, MD—Deputy Director (acting), Office of Hematology Oncology Products, U.S. Food and Drug Administration
- Levi Garraway, JD, PhD—Senior Vice President, Global Development & Medical Affairs, Eli Lilly; Director, Joint Center for Cancer Precision Medicine
- Amy Kapczynski, JD—Professor of Law and Faculty Director, Global Health Justice Partnership, Yale Law School
- Aaron Kesselheim, MD, JD, MPH—Associate Professor of Medicine, Harvard Medical School
- Ellen Sigal, PhD—Chairperson and Founder, Friends of Cancer Research
3:00 p.m. – 3:15 p.m.
Coffee Break
3:15 p.m. – 4:45 p.m.
Panel 5: Legal and Policy Issues Associated with Cutting-Edge Cancer Treatments
Moderator:
Joseph Ross, MD, MHS—Associate Professor of Medicine (General Medicine) and Associate Professor of Public Health (Health Policy), Yale School of Medicine
Panelists:
- Roy Herbst, MD, PhD—Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital
- Jorge Lopez, Jr., JD—Executive Vice President and General Counsel, Memorial Sloan Kettering Cancer Center
- Nicholson Price, JD, PhD—Assistant Professor of Law, University of Michigan Law School
- Jessica Roberts, JD—Associate Professor and Director, Health Law & Policy Institute, University of Houston Law Center
- Charles Sawyers, MD—Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
- Deborah Schrag, MD, MPH—Chief, Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School
4:45 p.m. – 6:00 p.m.
Closing Reception
Venue: Alumni Reading Room
(Heavy food to be served for those traveling immediately thereafter)
Co-Sponsors
Yale Cancer Center
Smilow Cancer Hospital at Yale New Haven
Yale Health Law and Policy Society (YHeLPS)
Yale Journal of Health Policy, Law, and Ethics
This event is supported by the Oscar M. Ruebhausen Fund at Yale Law School.
